4//SEC Filing
Davis Chaim 4
Accession 0001491519-20-000003
CIK 0000896747other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 2:59 PM ET
Size
5.4 KB
Accession
0001491519-20-000003
Insider Transaction Report
Form 4
Davis Chaim
Director
Transactions
- Purchase
Common Shares
2020-03-02$0.07/sh+528,571$37,000→ 2,978,486 total(indirect: By Revach Fund, LP)
Footnotes (3)
- [F1]These restricted common shares were issued on 3/2/20 in connection with a private placement dated 2/20/20. The Revach Fund, LP was one of the accredited investors who participated in the private placement. 528,571 units were purchased at $0.07 per share; resulting in a total purchase price of $37,000. Davis is a managing member of Revach Group, LLC which operates as the general partner for Revach Fund, LP. Davis serves as the Chairman of the Board of American Bio Medica Corporation.
- [F2]The price per unit in the private placement was $0.07.
- [F3]The common shares are in the name of Revach Fund, LP. The reporting person (Davis) is a managing member of Revach Group, LLC which operates as the general partner for Revach Fund, LP.
Documents
Issuer
AMERICAN BIO MEDICA CORP
CIK 0000896747
Entity typeother
Related Parties
1- filerCIK 0001491519
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 2:59 PM ET
- Size
- 5.4 KB